Weighted change-point method for detecting differential gene expression in breast cancer microarray data

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wang, Yao ^a   Sun, Guang ^b   Ji, Zhaohua ^a,c   Xing, Chong ^a,d   Liang, Yanchun ^a  

^a JILIN UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^c INNER MONGOLIA NORMAL UNIVERSITY   (China)

^d CHANGCHUN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FALSE POSITIVE RESULT; GENE EXPRESSION; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; NONPARAMETRIC TEST; NUCLEOTIDE SEQUENCE; RECEIVER OPERATING CHARACTERISTIC; SIMULATION; WEIGHTED CHANGE POINT STATISTICS; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENETICS; HUMAN; METHODOLOGY; MONTE CARLO METHOD;

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

BREAST NEOPLASMS; FEMALE; HUMANS; MONTE CARLO METHOD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IMMUNOLOGIC;

EID: 84856046944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029860     Document Type: Article

References (59)

1. Brent R, (2000) Genomic biology. Cell 100: 169-183.
2. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24 (3): 227-235.
3. Liang P, Pardee AB, (2003) Analysing differential gene expression in cancer. Nature Reviews Cancer 3: 869-876.
4. Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423.
5. Efron B, Tibshirani R, Storey J, Tusher V, (2001) Empirical Bayes analysis of a microarray experiment. J Am Stat Assoc 96: 1151-1160.
6. Pan W, Lin J, Le C, (2003) A mixture model approach to detecting differentially expressed genes with microarray data. Funct Integr Genomics 3 (3): 117-124.
7. Storey JD, Tibshirani R, (2003) SAM thresholding and false discovery rates for detecting differential gene expression in DNA microarrays, in the Analysis of Gene Expression Data: Methods and Software, In: Parmigani G, Garrett ES, Irizarry RA, Zeger SL, editors. New York Springer.
8. Lian H, (2007) MOST: detecting cancer differential gene expression. Biostatistics 9 (3): 411-418.
9. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in Prostate Cancer. Science 10 (310): 644-648.
10. MacDonald JW, Ghosh D, (2006) COPA-cancer outlier profile analysis. Bioinformatics 22: 2950-2951.
11. Lyons-Weiler J, Patel S, Becich MJ, Godfrey TE, (2004) Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics 5: 110.
12. Hu JH, (2008) Cancer outlier detection based on likelihood ratio test. Bioinformatics 24 (19): 2193-2199.
13. Tibshirani R, Hastie T, (2007) Outlier sums for differential gene expression analysis. Biostatistics 8: 2-8.
14. Wu B, (2007) Cancer outlier differential gene expression detection. Biostatistics 8 (3): 566-575.
15. Ji ZH, Wang Y, Wu CG, Wu XZ, Xing C, Liang YC, (2010) Mean, Median and Tri-Mean Based Statistical Detection Methods for Differential Gene Expression in Microarray Data. 3rd International Congress on Image and Signal Processing, 3rd International Conference on BioMedical Engineering and Informatics (CISP'10-BMEI'10) 7: 3142-3146.
16. Lian H, (2008) MOST: detecting cancer differential gene expression. Biostatistics 9 (3): 411-418.
17. Ji ZH, Wu CG, Wang Y, Guan RC, Tu HW, et al. (2010) Tri-Mean Based Statistical Differential Gene Expression Detection. Int J Data Mining and Bioinformatics In press.
18. Wang Y, Wu C, Ji Z, Wang B, Liang Y, (2011) Non-Parametric Change-Point Method for Differential Gene Expression Detection. PLoS ONE 6 (5): e20060.
19. Tan ZP, Miao BQ, (2000) Nonparametric Statistical Inference for Distribution Change Point Problems. Journal of China University of Science and Technology 6 (3): 270-276.
20. Griner EM, Kazanietz MG, (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nature Reviews Cancer 7: 281-294.
21. Kumar D, (2011) Project information of "Functional Characterization of CCDC130 Gene". Available:http://projectreporter.nih.gov/project_info_description.cfm?icde=0&aid=7560184 via the internet. Accessed 20 Aug 2011.
22. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, et al. (2002) Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 196 (2): 163-70.
23. Field JK, Liloglou T, Warrak S, Burger M, Becker E, et al. (2005) Methylation discriminators in NSCLC identified by a microarray based approach. Int J Oncol 27 (1): 105-11.
24. Smith PG, Wang F, Wilkinson KN, Savage KJ, Klein U, et al. (2005) The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood 105 (1): 308-16.
25. Han YC, Zeng XX, Wang R, Zhao Y, Li BL, et al. (2007) Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer. Article in Chinese. Ai Zheng 26 (1): 48-53.
26. Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, et al. (2005) SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65 (9): 3542-7.
27. Arce L, Yokoyama NN, Waterman ML, (2006) Diversity of LEF{pipe}[sol]{pipe}TCF action in development and disease. Oncogene 25: 7492.
28. Liu Y, Gao M, Lv YM, Yang X, Ren YQ, et al. (2011) Confirmation by Exome Sequencing of the Pathogenic Role of NCSTN Mutations in Acne Inversa (Hidradenitis Suppurativa). Journal of Investigative Dermatology 131 (7): 1570-1572.
29. Chong PK, Lee H, Loh MC, Choong LY, Lin Q, et al. (2010) Upregulation of plasma C9 protein in gastric cancer patients. Proteomics 10 (18): 3210-21.
30. Pasini FS, Maistro S, Campofiorito CM, Mangone FR, Walder F, et al. (2006) SCARB2 and CSNK1 double negative mRNA expression seems to be predictive of the presence of non-compromised lymph nodes in oral squamous cell carcinoma. Proc Amer Assoc Cancer Res Volume 47.
31. Davies SR, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG, (2008) Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance. J Exp Ther Oncol 7 (4): 327-38.
32. Lu J, McKinsey TA, Nicol RL, Olson EN, (2000) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97 (8): 4070-4075.
33. Glozak MA, Seto E, (2007) Histone deacetylases and cancer. Oncogene 26: 5420-5432.
34. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M, (2000) Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues. Mod Pathol 13 (9): 988-993.
35. Kim JH, You KR, Kim IH, Cho BH, Kim CY, et al. (2004) Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology 39 (1): 129-38.
36. Renier C, Vogel H, Offor O, Yao C, Wapnir I, (2010) Breast cancer brain metastases express the sodium iodide symporter. Journal of Neuro-Oncology 96 (3): 331-336.
37. Hayashi H, Nabeshima K, Aoki M, Hamasaki M, Enatsu S, et al. (2010) Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion. Int J Cancer 126 (11): 2563-74.
38. Cheng CW, Yu JC, Wang HW, Huang CS, Shieh JC, et al. (2010) The clinical implications of MMP-11 and CK-20 expression in human breast cancer. Clin Chim Acta 411 (3-4): 234-41.
39. Miettinen M, (1987) Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Arch Pathol Lab Med 111 (9): 813-8.
40. Yang Y, Wu PP, Wu J, Shen WW, Wu YL, et al. (2008) Expression of anion exchanger 2 in human gastric cancer. Exp Oncol 30 (1): 81-7.
41. Dunn TA, Chen S, Faith DA, Hicks JL, Platz EA, et al. (2006) A Novel Role of Myosin VI in Human Prostate Cancer. Am J Pathol 169 (5): 1843-1854.
42. Drenth JP, Goertz J, Daha MR, vander Meer JW, (1996) Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells. Immunology 88: 355-62.
43. Han X, Guo J, Deng W, Zhang C, Du P, et al. (2008) High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling. BMC Genomics 9: 476.
44. Motadi L, Dlamini Z, Mbita Z, Bhoola K, (2005) Involvement of RbBP6 gene and apoptosis in the pathogenesis of lung cancer. Proc Amer Assoc Cancer Res Volume 46, Abstract # 3633.
45. Hayashi H, Nabeshima K, Aoki M, Hamasaki M, Enatsu S, et al. (2010) Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion. Int J Cancer 1;126 (11): 2563-74.
46. Zhang H, Constantine R, Vorobiev S, Chen Y, Seetharaman J, et al. (2011) UNC119 is required for G protein trafficking in sensory neurons. Nature Neuroscience pp. 874-880 Volume: 14, Pages.
47. Entschladen F, Zänker KS, Powe DG, (2011) Heterotrimeric G protein signaling in cancer cells with regard to metastasis formation. Cell Cycle 1;10 (7): 1086-91.
48. Menigatti M, Cattaneo E, Sabates-Bellver J, Ilinsky VV, Went P, et al. (2009) The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Molecular Cancer 8: 124.
49. Wu P, Tian Y, Chen G, Wang B, Gui L, et al. (2010) Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. Cell Death Differ 17 (1): 109-18.
50. Seiler A, Schneider M, Förster H, Roth S, Wirth EK, et al. (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8 (3): 237-48.
51. Ma Z, Nie Z, Luo R, Casanova JE, Ravichandran KS, (2007) Regulation of Arf6 and ACAP1 signaling by the PTB-domain containing adapter protein GULP. Curr Biol 17 (8): 722-727.
52. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, et al. (2004) Requirement for Arf6 in breast cancer invasive activities. PNAS vol. 101 (17): 6647-6652.
53. Zegerman P, Bannister AJ, Kouzarides T, (2000) The putative tumour suppressor Fus-2 is an N-acetyltransferase. Oncogene 19 (1): 161-3.
54. Gibb1 EA, Brown CJ, Lam WL, (2011) The functional role of long non-coding RNA in human carcinomas. Molecular Cancer 10: 38.
55. Tomonaga T, Matsushita K, Ishibashi M, Nezu M, Shimada H, Ochiai T, et al. (2005) Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression Induces aneuploidy. Cancer Res 65: 4683.
56. Nandana S, Ellwood-Yen K, Sawyers C, Wills M, Weidow B, et al. (2010) Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model. Prostate 1; 70 (6): 591-600.
57. Graham K, Morenas A, Tripathi A, King C, Kavanah M, et al. (2010) Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. British Journal of Cancer (2010) 102: 1284-1293.
58. West M, Blanchette C, Dressman H, Huang E, Ishida S, et al. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proceedings of the National Academy of Sciences of the United States of America 98: 11462-11467.
59. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics Genome Biology vol. 5: R80.